Effects of Minoxidil Gel on Burn Wound Healing in Rats by Khazaelia, Payam et al.
Original Article
Effects of Minoxidil Gel on Burn Wound Healing in Rats 
Payam Khazaelia*, Mohammad Karamouzianb, Shohreh Rohanic, 
Behnam Sadeghiradd and Nima Ghalekhanie
aSchool of Pharmacy and Pharmaceutical Research Center, Kerman University of 
Medical Sciences, Kerman, Iran. bRegional Knowledge Hub, and WHO Collaborating 
Centre for HIV Surveillance, Institute for Futures Studies in Health, Kerman University 
of Medical Sciences, Kerman, Iran. cSchool of Pharmacy, Kerman University of Medical 
Sciences, Kerman, Iran. dNeuroscience Research Center, Institute of Neuropharmacology, 
Kerman University of Medical Sciences, Kerman, Iran. eResearch Center for Health 
Services Management, Institute for Futures Studies in Health, Kerman University of Medical 
Sciences, Kerman, Iran.
Abstract
Minoxidil has been reported to inhibit in-vitro fibroblast proliferation and lysyl hydroxylase 
activity, a key enzyme in collagen biosynthesis. These in-vitro effects proposed minoxidil to be 
a potential antifibrotic agent. The present study aimed to investigate the effects of minoxidil gel 
on wound healing procedure in a second-degree burn model in rats.
 Wistar rats were anesthetized and a second-degree burn was induced on the back of Wistar 
rats using a heated 2 cm diameter metal plate. Experimental groups received 2% or 5% topical 
minoxidil gel, dexpanthenol or sliver sulfadiazine. Histological parameters including collagen 
content, angiogenesis, number of preserved follicles and necrosis along with tensile strength of 
burn wound area were assessed on days 3, 7, 14 and 21 post-injury.
Microscopic evaluation of specimens collected from sample animals were consistent and 
showed a second-degree burn. Main histological findings regarding minoxidil topical usage 
showed that collagen content and tensile strength of burned area did not differ between groups. 
However, minoxidil increased the number and diameter of blood vessels significantly compared 
with other groups.
Although minoxidil improved the process of wound-healing, our results did not support the 
proposed idea of its usage as an antifibrotic agent. However, to reject its possible effects as an 
antifibrotic agent, more objective animal models should be developed and studied.
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Introduction
Minoxidil (MOX) is a pyrimidine derivative 
initially used as a potent antihypertensive agent 
which is a vasorelaxant agent that opening 
ATP-sensitive K channel (1, 2). Minoxidil 
induces hypertrichosis as a common side effect 
(2, 3), which result in development of topical 
formulations for treatment of male pattern 
baldness. Almost three decades ago, Cohen et al 
showed that MOX could have direct effects on 
the proliferation and morphology of epidermal 
cells (4). A few years later, Murad and Pinnel 
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begins with the appearance of fibroblasts and its 
main functions are the restoration of collagen 
lattices and angiogenesis. The strength of the 
wound improves during this phase, and is 
proportional to the production of collagen (25, 
26). The remodeling, begins after a few weeks, 
and may last years. During this stage, due to a 
dynamic balance between collagen synthesis and 
degradation wound strength increases with no 
actual change in collagen content (22-24). The 
final process of healing is contraction; it is the 
migration of the wound edges toward the center 
which results in reducing the wound size and 
fibroblasts are responsible for wound contraction 
(22-24).
Based on MOX properties and its effects on 
fibroblasts, collagen formation, and angiogenesis 
it is probable that a topical formulation of MOX 
may have influence on the processes involved 
in phase I and II of scar formation. Hence, in 
this study, we aimed to investigate the effects 
of MOX topical gel formulation on the healing 
process of a murine partial second-degree burn 
model and to compare MOX effects with two 
routine burn wound treatments (dexpanthenol 
ointment and silver sulfadiazine cream).
Experimental
Drugs
To prepare 2% and 5% gel formulations, 
MOX powder (purchased from MERCK, 
Germany) was dissolved in appropriate amount 
of PEG 400. Then, boiling ethanol was added 
to the heated MOX solution while stirring. This 
solution was added to the carbomer containing 
mixture and stirred until being cooled. Silver 
sulfadiazine cream 1% (Sina-Daru Inc., Iran) 
and dexpanthenol 5% (Pars-Daru Inc., Iran) 
ointments were commercially purchased.
Experimental protocol
An experimental skin burn model was 
prepared as described below. Wistar albino 
rats were anaesthetized with an intraperitoneal 
injection of ketamine (60 mg Kg-1) and xylazine 
HCL (8 mg Kg-1). Mean age for test animals 
was 75 ± 15 days and their mean weight was 
215 ± 21g. The skin of dorsum was shaved and 
thoroughly depilated. Burn injury was made 
demonstrated that MOX inhibits fibroblast 
proliferation without causing cytotoxicity (5).
In addition to inhibitory effects of MOX on 
fibroblasts proliferation and activity, it showed 
inhibitory effects on keratinocytes proliferation 
and delays keratinocytes differentiation and 
senescence in-vitro (6). It is reported that, MOX 
can up-regulates the expression of vascular 
endothelial growth factor (VEGF), which has 
central role in formation of new blood cells and 
promoting angiogenesis, and affects eicosanoid 
production, that have anti-inflammatory 
properties and stimulate collagen synthesis, and 
improve blood flow to the skin(3,7). Several 
studies reported that MOX inhibited lysyl 
hydroxylase (LH) and dramatically reduced the 
level of LH activity in dermal fibroblasts (4,8-
16). LH catalyzes the hydroxylation of lysine 
residues in peptide linkages and it is a key post-
translational modifying enzyme in collagen 
biosynthesis (8, 14, 17).
MOX effects on fibroblast proliferation 
and metabolism, and its interference with 
crucial steps in collagen biosynthesis, revealed 
its potential ability to inhibit the contractile 
properties of the cells responsible for wound 
contraction. Hence, it is suggested that it might 
be an effective topical treatment for fibroses, 
hypertrophic scar, or keloids, where collagen 
accumulates (5, 18). Many compounds with 
promising activities against collagen synthesis 
or fibroblast proliferation are disqualified from 
use because of their toxicity, but MOX appears 
to fulfill all the criteria;it modulates a range of 
fibroblast activities without toxic effects (18), 
inhibits collagen synthesis and cross-linking 
(16), and collagen lattices contraction (19), and 
has influence on vascularization (7) and skin 
blood flow (2).
One of the most important wounds are 
burn wounds which is Susceptible to infection 
because of vascular necrotic tissue.  Burn wound 
infection is main reason of morbidity in these 
patients (20, 21). 
 Scar formation in the process of burn 
wound healing involves three phases, which 
merge and overlap, the inflammatory phase, 
proliferative phase and remodeling phase (22-
24). The main function of the first phase is to 
prepare the wound for repair. The second phase 
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as a contact burn with a round 2 cm diameter 
metal plate (105 ˚C, 5 seconds). An hour after 
burn injury, each animal received an appropriate 
amount of topical formulation with regards to 
the assigned group. Topical applications were 
repeated every day and continued until 12 h 
before sample collection. 
Animals were assigned randomly to either 
control or experimental groups. Experimental 
groups was further subdivided into five groups 
as follows: Group 1 received topical blank gel 
(formulated gel base without minoxidil), group 
2 received topical dexpanthenol ointment as 
standard healing agent, group 3 received topical 
sliver sulfadiazine (SSD) ointment as standard 
burn treatment (27, 28), group 4 and 5 received 
2% and 5% topical minoxidil gel (n > 5 rats per 
group per time point, total of 257 animals).
In order to collect specimens, the animals 
were euthanized at 3, 7, 14 and 21 days after 
inducing burn injury in a chamber filled with 
excessive amount of diethyl ether. These 
specimens were preserved in 10% formalin for 
light microscopic study. Animals in this study 
were treated strictly according to the supervision 
of the Ethics Committee of Kerman University 
of Medical Sciences.
Histological assessments
The parameters investigated included 
angiogenesis and their total diameter, number of 
preserved follicles, reticular fibers and collagen 
formation, the number of inflammatory cells, 
and necrosis (29, 30). From each sample, two 
slides were prepared and the related parameters 
were quantified in at least three randomly 
selected fields. All histological procedures were 
performed by two independent blind observers. 
Standard histological slices were stained 
using hematoxylin–eosin (blood vessels, 
necrosis, and inflammatory cells), Gomori silver 
stain (reticular fibers) and Van Gieson staining 
(collagen). The assessed parameters according 
to day of sacrifice were as follows: day3: total 
number and diameter of blood vessels, number of 
inflammatory cells and number of vital follicles; 
day 7, 14 and 21: as day 3 with percentage of 
reticular fibers and collagen (27, 28). 
Angiogenesis has been determined by 
measuring the number and sum of diameters 
of blood vessels. Two microscopic fields (mag. 
6.3×) in the central part of the burned area 
were analyzed to determine this parameter (27, 
28). Inflammatory cells have been counted in 
three visual fields in the middle portion of the 
burned area (mag. 40×) between the deepest 
layer of follicles and the muscular layer of the 
skin (27, 28). Necrosis has been scored using a 
modified Suzuki scale (mag. 25×) (31): Grade 
1: necrosis within the epidermal layer; Grade 2: 
necrosis up to the deepest layer of hair follicles; 
Grade 3: necrosis exceeding the deepest layer 
of hair follicles; Grade 4: necrosis exceeding 
the muscular layer. The number of preserved 
follicles has been counted in three microscopic 
fields (mag. 25×) in the middle of the burned 
area and examining the deepest layer of hair 
follicles. Reticular fibers and collagen have been 
determined as percentages in two microscopic 
fields (mag. 40×) on each margin of the burned 
area between the deepest follicles and the 
muscular layer (27, 28).
Tensile strength
Tensile strength (the force required to open 
the healing skin) was used to measure the 
amount of healing (32, 33). The tensile strength 
of burned skin in control and treatment groups 
was measured on day 3 and day 7 post-injury 
using an industrial tensiometer (500 N, Bual, 
Germany). Strips of the burned wound were 
excised to compare changes in breaking strength 
as a function of time after wounding. The 
specimens were stretched between the machine 
clamps and the maximum force generated to torn 
specimens apart was measured (32, 33).
Statistical analysis
To compare tensile strength, number and 
diameter of blood vessels, number of preserved 
follicles and percentage of reticular fibers and 
collagen in different experimental groups, 
ANOVA test followed by Tukey or Scheffe post-
hoc tests were used. In order to compare the 
number of inflammatory cells and necrosis among 
groups, Kruskal-Wallis test was used. Finally, 
linear regression model was used in order to assess 
the time trend of each parameter in different study 
groups. All data collected from experiments were 
analyzed using SPSS version 15.0.
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Results
There were no changes in food intake, water 
consumption and body weight of the animals 
subjected to burn injury. The wound lesions 
showed swelling immediately after the burn 
injury. Thereafter, the lesions became necrotic 
and were covered with a crust by day 7. The burn 
sizes did not differ between day 1 and day 7. On 
the other hand, the burn wounds decreased in 
size from day 7 to day 14. Besides, there was no 
significant difference between control and blank 
gel animals in any of histological assessment or 
breaking tensile strength.
There was a marked increase in blood vessel 
formation, and enhanced proliferation of hair 
follicles because of treatment with minoxidil 
gels post-burn (Figure 1). Total number (BVN) 
and diameter (BVD) of blood vessels showed no 
difference between different groups on day 3 (p = 
0.202, F = 1.56 and p = 0.108, F = 1.99 for BVN 
and BVD respectively). However, minoxidil 5% 
gel formulation showed a significant increase 
in BVN and BVD compared with the control 
group after a week (p = 0.009 and p = 0.01 
respectively). The difference between minoxidil 
5% and dexpanthenol or SSD ointments showed 
a borderline significance (p = 0.066 and p = 
0.051 for BVN and p = 0.069 and p = 0.053 for 
BVD).
On day 14th post-burn, both minoxidil 
formulations showed a significant increased 
BVN compared to control (p = 0.007 and p = 
0.001 for 2% and 5% formulations respectively). 
However, only 5% minoxidil gel increased 
BVD significantly (p = 0.006). While there was 
no significant difference between minoxidil 
formulations, the difference between minoxidil 
5% gel and both dexpanthenol and SSD in total 
BVN was statistically significant (p = 0.015 and 
Figure 1. histological assessments in different treatment groups during 21 days post-burn.
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p = 0.004 respectively). A borderline significant 
difference was observed between minoxidil 5% 
and dexpanthenol or SSD in total BVD (p = 
0.061 and p = 0.052 respectively).
Three weeks after injury, minoxidil 
formulations showed still a significant higher 
amount of blood vessels formation (p = 0.009 
and p = 0.033 for 2% and 5% formulations in 
BVD respectively and p < 0.001 and p = 0.001 for 
2% and 5% formulations in BVN respectively). 
In spite of the significant difference between 
minoxidil gel formulations (2% and 5%) and 
SSD ointment in total BVD (p = 0.024 and 
0.004 respectively) and BVN (p = 0.005 and p 
< 0.001 respectively), the difference between 
two minoxidil gel formulations was not 
statistically significant. Besides, the increase 
of BVN caused by both of the minoxidil gel 
formulations was more than dexpanthenol 
ointment, and their difference was statistically 
significant (p = 0.001 and p = 0.037 for 2% and 
5% minoxidil gels). However, this difference 
was significant only for minoxidil 5% gel 
for BVD in comparison with dexpanthenol 
ointment (p = 0.014).
Evaluation of collagen and reticulin 
production during days post-injury showed 
that the difference between treatment groups 
with control or blank gel animals was not 
statistically significant. Reticular fibers or 
collagen percentage did not differ statistically 
between treatment groups either. Compared with 
control, only dexpanthenol ointment decreased 
the number of inflammatory cells during 21 days 
post-injury significantly (p = 0.002). Minoxidil 
formulations throughout the experiments 
increased the number of follicles compared with 
blank gel and control animals significantly (1.5 
± 0.7 increase in the number of follicles per day, 
p = 0.03 and 2.1 ± 0.7 increase in the number 
of follicles per day, p = 0.002 for 2% and 5% 
minoxidil gels). Less necrosis was observed in 
dexpanthenol animals during days post-injury 
compared with controls (p = 0.027), while other 
treated animals did not show any significant 
decreasing trend in necrosis score.
Comparing tensile strength in different 
groups, a significant difference was observed 
(p = 0.001, F = 16.0 and p = 0.003, F = 4.6 for 
day 3 and 7 post-injury respectively) (Figure 2). 
The results showed that 1.84 ± 0.51 KgN per day 
was added to the maximal stress until the wound 
disrupted (p = 0.001). Compared with the control 
group, only wounds treated with dexpanthenol 
demonstrated a significant increase in the 
amount of force needed for wound disruption 
(2.12 ± 0.3, p < 0.001).
Discussion 
To investigate the effects of minoxidil on 
wound healing, it was formulated for the first 
 
 
Figure 2. Tensiometry assessment. Breaking tensile force (Kg/N) in different treatment groups’ day 3 
post-burn (left) and day 7 post-burn (right). 
 
Figure 2. Tensiometry assessment. Breaking tensile force (Kg/N) in different treatment groups’ day 3 post-burn (left) and day 7 post-
burn ( ight).
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time in this study as a topical gel that could be 
readily used. Our results showed that neither 2%, 
nor 5% minoxidil gel altered collagen content 
of burn wounds throughout healing process 
compared to the control group animals. Besides, 
the tensile strength of burned area of the skin 
as an indicator of wound contraction was not 
different between minoxidil treated and control 
animals.
Burn injury is the first and the foremost cause 
of damage to the skin. Although the burned 
patient has many problems to face during the 
stages of recovery from a burn injury, the major 
and persisting problems for survivors are those 
associated with the problems of healing and the 
outcome of healing in terms of scarring. Problems 
associated with wound management, treatment 
and healing have always been important 
challenges for clinicians and investigators (34).
Wound contraction is the centripetal or 
concentric reduction in size of an open wound. 
It is a major component of second-intention 
wound healing, and the center for contraction 
is granulation tissue. The basic components of 
granulation tissue are fibroblasts, macrophages, 
capillaries, and collagen (35). Furthermore, the 
sources of cells involved in the healing of skin 
include fibroblasts, smooth muscle cells and 
endothelial cells in the dermis and associated 
structures (22, 36).
Minoxidil is a direct acting peripheral 
vasodilator recommended orally for treatment of 
severe hypertension (3, 37). In addition, it was 
unexpectedly found to stimulate hair growth. 
This major side effect of minoxidil led to its 
clinical use for treatment of common baldness 
(androgenic alopecia) and alopecia areata (38). 
Minoxidil was later reported to have direct 
effects on the proliferation and morphology of 
epidermal cells in concentrations comparable 
to those used clinically in treatment of alopecia 
(4). It has been proposed as a potential topical 
inhibitor of wound contraction and proliferative 
scaring (5-7, 18, 19, 39-41). Suggestions for 
this application are derived from in-vitro studies 
demonstrating that minoxidil inhibits fibroblast 
proliferation and activity (5, 18, 42-44).
Besides, Minoxidil is reported to depress 
lysyl hydroxylase activity, a key enzyme for 
collagen crosslinking, selectively in cultured 
human skin fibroblast and reduce collagen 
lattices (5, 11, 16, 19, 45). Minoxidil is also 
able to induce vasodilation, stimulate cutaneous 
blood flow and up-regulates the expression 
of VEGF, which is related to the formation of 
capillaries (2, 7).
In contrast to its stimulatory effects on 
epithelial cells, minoxidil has been shown to 
have a variety of inhibitory effects on fibroblasts 
in-vitro. These effects occur at concentrations 
much lower than 2% (approximately 100 
mM) topical solution that is applied to intact 
skin to generate hair growth (3). In fact, at 
concentrations greater than 4 mM, minoxidil 
exhibits a significant cytotoxicity to the 
fibroblasts in-vitro (18, 45). Because this study 
involved direct topical application of minoxidil 
to target cells in burned wounds, 2% and 5% 
formulations were chosen. Besides, due to the 
high alcohol content of commercial topical 
solutions, minoxidil was formulated as a topical 
gel. Despite use of high minoxidil doses and the 
least irritating formulations, inhibitory effects 
were not demonstrated.
In-vitro culture is an incomplete method 
of studying wound dynamics because of the 
complexity of the in-vivo interactions between 
tissue tension, effector cells, extracellular 
matrix, humoral factors and locally derived 
growth factors (35, 46, 47). Reproducible 
animal models such as the one used in this study 
are useful tools to verify and validate the results 
of in-vitro study of therapeutic agents that may 
potentially alter wound healing process. Despite 
the abundance of the in-vitro data previously 
cited the multilevel inhibition of fibroblast 
metabolism and contraction of collagen 
lattices by minoxidil (5, 18, 19, 42, 45), this 
in-vivo study did not demonstrate comparable 
fibroblastic or collagen production inhibition 
considering the histological assessments and 
tensile strength.
If tensile strength can be assumed to be 
directly related to collagen crosslinking, the 
inhibition of lysyl hydroxylase by minoxidil, 
as demonstrated to occur in-vitro, apparently 
did not occur in this in-vivo model. After 
the discovery of the inhibitory action on LH 
gene expression, minoxidil was postulated to 
possess anti-fibrotic properties by reducing 
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R. Minoxidil specifically decreases the expression of 
lysine hydroxylase in cultured human skin fibroblasts. 
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activity relationship of minoxidil analogs as inhibitors 
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SR. Characterization of a partial cDNA for lysyl 
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the total number of hydroxylysine residues in 
the collagen molecule and consequently, the 
formation of hydroxyallysine cross-links (5, 9, 
13). To achieve a reduction in hydroxyallysine 
crosslinking, only a decrease in the number of 
telopeptidehydroxylysine residues is required, 
but not a considerable reduction of the total 
number of hydroxylysine residues in the 
collagen molecule (16).
Moreover, minoxidil appeared to be able to 
decrease the LH mRNA level, but remarkably, 
no consistent decrease in the total number of 
pyridinoline cross-links was found in the matrix 
deposited by fibroblasts. Since minoxidil does 
not completely inhibit LH gene expression at a 
concentration of 500 µM, an explanation could 
be that residual gene expression is sufficient for 
hydroxylation of telopeptide lysine residues to 
a level of normally found in collagen produced 
by fibroblasts (16).
Our results demonstrated that minoxidil 
actively induced angiogenesis in burned area of 
the skin from first days of topical application. 
Minoxidil is either considered as a factor that 
acts directly on VEGF synthesis, or indirectly, 
by stimulating the synthesis of other cytokines 
or growth factors which themselves act directly 
on VEGF synthesis. It is reported that abundant 
VEGF production may ultimately lead to the 
formation of new blood vessels to maintain 
adequate microvascularization (7). 
We should also acknowledge the limitations 
of this study. Investigating pharmacokinetic 
and pharmacodynamic parameters including 
dose-response characteristics, bioavailability, 
absorption and metabolism parameters of 
minoxidil gel formulations could be more helpful 
for inferring the in-vivo results. Combination 
therapies and mixing treatment groups like 
animals receiving minoxidil formulations and 
SSD or dexpanthenol ointments could have 
resulted in more practical and applicable 
findings regarding burn wound healing. 
Nonetheless, such grouping patterns inevitably 
increased the number of experimental animals, 
which of course was not feasible in this study.
Conclusion
In conclusion, although topical minoxidil 
improved the process of wound healing, our 
results did not support the proposed idea of 
minoxidil usage as an anti-fibrotic agent, because 
it did not alter the collagen content or tensile 
strength of burned area of the skin. However, in 
order to reject the possible effects of minoxidil 
as an anti-fibrotic agent, more objective animal 
models, e.g. hypertrophic scar model should be 
developed and studied. 
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